Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | ISO | Slfn4 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of SLFN4 mRNA | CTD | PMID:15834898 | 17alpha-ethynylestradiol | multiple interactions | ISO | Slfn3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLFN3 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | ISO | Slfn3 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SLFN3 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | Slfn3 (Mus musculus) | 6480464 | Estradiol results in increased expression of SLFN3 mRNA | CTD | PMID:19484750 | 17beta-estradiol | multiple interactions | ISO | Slfn4 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLFN4 mRNA | CTD | PMID:32741896 | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Slfn4 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLFN4 mRNA | CTD | PMID:32741896 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Slfn3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLFN3 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slfn4 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLFN4 mRNA | CTD | PMID:34747641 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SLFN12 mRNA | CTD | PMID:21934132 and PMID:33167477 | aristolochic acid A | multiple interactions | ISO | Slfn4 (Rattus norvegicus) | 6480464 | [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of SLFN4 mRNA | CTD | PMID:23912714 | belinostat | increases expression | EXP | | 6480464 | belinostat results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SLFN12 exon and Benzo(a)pyrene affects the methylation of SLFN12 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of SLFN12 mRNA | CTD | PMID:31163220 | bisphenol A | decreases expression | ISO | Slfn4 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLFN12 mRNA and bisphenol A results in decreased expression of SLFN4 mRNA | CTD | PMID:25181051 more ... | cannabidiol | decreases expression | EXP | | 6480464 | Cannabidiol results in decreased expression of SLFN12 mRNA | CTD | PMID:33244087 | carbon nanotube | increases expression | ISO | Slfn3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | clofibrate | decreases expression | ISO | Slfn3 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of SLFN3 mRNA | CTD | PMID:17585979 | copper(II) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of SLFN12 mRNA | CTD | PMID:19549813 | DDT | increases methylation | ISO | Slfn4 (Rattus norvegicus) | 6480464 | DDT results in increased methylation of SLFN4 gene | CTD | PMID:31682807 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | EXP | | 6480464 | entinostat results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | fenvalerate | increases expression | ISO | Slfn4 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of SLFN4 mRNA | CTD | PMID:30307764 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SLFN12 mRNA | CTD | PMID:20655997 and PMID:27905399 | fragrance | increases expression | EXP | | 6480464 | Perfume results in increased expression of SLFN1 mRNA | CTD | PMID:24768652 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLFN12 mRNA | CTD | PMID:35811015 | mercury dibromide | increases expression | EXP | | 6480464 | mercuric bromide results in increased expression of SLFN12 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of SLFN12 mRNA | CTD | PMID:28001369 | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of SLFN12 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | decreases expression | ISO | Slfn3 (Mus musculus) | 6480464 | Ozone results in decreased expression of SLFN3 mRNA | CTD | PMID:12763052 | paracetamol | multiple interactions | ISO | Slfn3 (Mus musculus) | 6480464 | MAP3K5 protein affects the reaction [Acetaminophen results in increased expression of SLFN3 mRNA] | CTD | PMID:18700144 | paracetamol | affects expression | ISO | Slfn3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLFN3 mRNA | CTD | PMID:17562736 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of SLFN12 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of SLFN12 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | Slfn3 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SLFN3 mRNA | CTD | PMID:37682722 | testosterone | multiple interactions | ISO | Slfn4 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of SLFN4 mRNA | CTD | PMID:32741896 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SLFN12 mRNA | CTD | PMID:24935251 more ... | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SLFN12 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLFN12 mRNA | CTD | PMID:23179753 more ... | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of SLFN12 mRNA | CTD | PMID:26272509 and PMID:27188386 | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLFN12 mRNA | CTD | PMID:27188386 | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of SLFN12 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of SLFN12 mRNA | CTD | PMID:22171008 | |